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“Overdiagnosis” and “misdiagnosis” in COPD literature
Key points
●● In the COPD literature, the terms “overdiagnosis” and “misdiagnosis” are often used 
interchangeably and almost always refer to a false positive diagnosis.
●● Use of spirometry with correct interpretation of the results can avoid a substantial proportion of 
cases of misdiagnosis of COPD.
Educational aims
●● To explore the use of the terms “overdiagnosis” and “misdiagnosis” in the COPD literature.
●● To identify the main sources of overdiagnosis and misdiagnosis in COPD.
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Overdiagnosis in the COPD literature generally refers to a false positive diagnosis (misdiagnosis). 
Misdiagnosis can be significantly reduced by performing spirometry in every patient with suspected 
COPD. http://ow.ly/zuAw30o7hiV
Challenges in the diagnostic process of chronic obstructive pulmonary disease (COPD) can result 
in diagnostic misclassifications, including overdiagnosis. The term “overdiagnosis” in general has 
been associated with variable definitions. In connection with efforts to reduce low-value care, 
“overdiagnosis” has been defined as a true positive diagnosis of a condition that is not associated 
with any harm in the diagnosed person. It is, however, unclear how the term “overdiagnosis” is 
used in the COPD literature. We conducted a rapid review of the literature to explore how the 
terms “overdiagnosis” and “misdiagnosis” are used in the context of COPD. Electronic searches of 
Medline were conducted from inception to October 2018, to identify primary studies that reported 
on over- and/or misdiagnosis of COPD using these terms. 28 articles were included in this review. 
Overdiagnosis and misdiagnosis in COPD were found to be used to describe five main concepts: 
1) physician COPD diagnosis despite normal spirometry (14 studies); 2) discordant results for COPD 
diagnosis based on different spirometry-based definitions for airflow obstruction (10 studies); 
3) COPD diagnosis based on pre-bronchodilator spirometry results (three studies); 4) comorbidities 
(e.g. heart failure or asthma) that affect spirometry and have clinical features which overlap with 
COPD (two studies); and 5) normalisation of abnormal (post-bronchodilator) spirometry at follow-up 
(one study). The terms “overdiagnosis” and “misdiagnosis” were often used interchangeably and 
almost always referred to a false positive diagnosis. Performing (technically correct) spirometry 
with correct interpretation of the results could probably reduce misdiagnosis in a large proportion 
of the misdiagnosed cases of COPD. In addition, guidelines need to provide a more acceptable 
consensus spirometric definition of airflow obstruction.
Review
Use of the terms “overdiagnosis” 
and “misdiagnosis” in the 
COPD literature: a rapid review
Background
Chronic obstructive pulmonary disease (COPD) is 
defined as “a preventable and treatable disease 
state characterised by airflow limitation that is not 
fully reversible. The airflow limitation is usually 
progressive and is associated with an abnormal 
inflammatory response of the lungs to noxious 
particles or gases, primarily caused by cigarette 
smoking” [1]. Despite COPD being a very common 
condition, there is no consensus on the diagnostic 
criteria for COPD [2]. COPD can be complex to 
diagnose, as a number of factors are relied upon 
to confirm the diagnosis, including a history of 
exposure to cigarette smoke or other noxious inhaled 
agents and the presence of chronic symptoms such 
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as cough, wheeze or dyspnoea, as well as confirmed 
persistent airflow limitation on spirometry.
Lack of consensus regarding diagnostic criteria 
relates in particular to spirometry-based definitions. 
A study that assessed the impact of four different 
widely used spirometry-based definitions of airflow 
obstruction and one self-reported definition 
demonstrated that the population prevalence 
estimate of COPD altered by as much as 200% 
depending on which definition was used [2]. The 
four spirometry-based definitions included: 1) forced 
expiratory volume in 1 s (FEV1)/forced vital capacity 
(FVC) <0.7 and FEV1 <80% predicted (Global Initiative 
for Chronic Obstructive Lung Disease (GOLD) stage 
2) [3]; 2) FEV1/FVC below the lower limit of normal 
(LLN) [4]; 3) FEV1/FVC <88% predicted in males and 
<89% predicted in females [5]; 4) FEV1/FVC <0.7 
(“fixed ratio”) (GOLD stage 1) [3].
In clinical practice, the GOLD definition of 
airflow obstruction based on post-bronchodilator 
FEV1/FVC of <0.7 is probably the most commonly 
used because it can be easily calculated, although 
the American Thoracic Society and the European 
Respiratory Society recommend the use of age- and 
sex-specific LLN for FEV1/FVC [6].
The need to use spirometry to diagnose COPD 
poses additional challenges beyond the lack of 
consensus about what constitutes relevant airflow 
obstruction. Spirometry requires that health 
professionals are trained in spirometry technique 
and patients need to be able to perform reproducible 
breathing manoeuvres. In many settings, especially 
in resource-constrained areas, a spirometer might 
not be readily available.
These challenges (lack of consensus on the 
definition of airflow obstruction, poorly performed 
spirometry and underuse of spirometry) can all 
have an impact on whether COPD is diagnosed in a 
patient or not and are associated with overdiagnosis, 
underdiagnosis and misdiagnosis of COPD.
The issues of overdiagnosis, underdiagnosis 
and misdiagnosis of COPD are not new. In recent 
years, there has been interest in overdiagnosis 
of different conditions, driven by an effort to 
address “too much medicine”, that is, healthcare 
interventions that have no net benefit for patients 
and may even result in harm [7]. In this context, 
overdiagnosis, especially related to cancer 
screening, has been defined as a true positive 
diagnosis of a condition that is not associated with 
any morbidity or mortality over a patient’s lifetime 
(for example, diagnosis of an in situ breast cancer 
in an elderly woman, which will not cause any 
symptoms during her lifetime and will not be the 
cause of her death [7]). Even though the prevalence 
of overdiagnosis and misdiagnosis of COPD has 
been reported widely in the literature, it is unclear 
how the terms “overdiagnosis” and “misdiagnosis” 
in the context of COPD have been used.
A previous review has focused on estimating 
the prevalence of COPD and identifying causes 
of underdiagnosis and overdiagnosis in different 
health systems but did not focus on the terminology 
used [8]. Additionally, there has been a scoping 
review on misdiagnosis in COPD [9]. We performed 
a review of the literature to assess how the term 
“overdiagnosis” is used in the context of COPD.
Literature review
We conducted electronic searches of Medline 
from inception to October 2018 using the 
following search terms: “overdiagnosis” AND 
(COPD OR chronic obstructive pulmonary disease 
OR emphysema). We included original studies 
of any study design that reported on over- and/
or misdiagnosis of COPD using these terms. We 
restricted our search to studies published in English. 
Relevant titles and abstracts were identified and 
eligible articles were included in this review. We 
also checked the reference lists of included studies.
From searches of Medline and PubMed, 42 
records were identified, and a further 19 records 
were identified from reference list searches. From 
these we retrieved 50 articles for full-text review but 
22 of these did not meet our selection criteria. 28 
studies were included in our review (figure 1). The 
studies were published between 2003 and 2018 
and were conducted in 13 countries.
Definitions of overdiagnosis
In examining the 28 eligible studies, we identified 
several different types of “overdiagnosis” and 
“misdiagnosis”, which we have grouped in the 
categories described in the next sections and listed 
Records identified through
database searching
(n=42)
Additional records identified
through other sources
(n=19)
Records screened
(n=61)
Full-text articles assessed
for eligibility
(n=50)
Studies included in
qualitative synthesis
(n=28)
Records excluded
(n=11)
Full-text articles 
excluded
(n=22)
  Did not use the term
    over-/misdiagnosis
  Not primary studies
  Non-English studies
Figure 1 Study flow diagram.
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in table 1. Further details on each of the included 
studies can be found in table 2.
Physician COPD diagnosis, 
but with normal spirometry
15 studies reported overdiagnosis or misdiagnosis 
if the physician’s diagnosis was discordant with the 
spirometry result, which showed either a normal or 
restrictive pattern [10–24]. A physician diagnosis with 
normal spirometry could have been a case in which 
the physician did not use spirometry to establish a 
diagnosis of COPD (and a normal spirometry was later 
found in the study) [10, 14–17, 21–23], or a case in 
which the physician “ignored” a normal spirometry 
result [12, 20, 24]. Most of these studies cited under-
utilisation of spirometry as the primary cause of 
overdiagnosis and misdiagnosis in this context. Five 
studies used the term “overdiagnosis” to capture 
these discordant cases of physician diagnosis and 
spirometry readings [10–13, 17]. Eight studies 
considered these cases to be misdiagnosed [14, 15, 
18–22, 24]. In two studies the terms “overdiagnosis” 
and misdiagnosis were used interchangeably to 
describe this concept [16, 23].
Fixed threshold for the definition 
of (post-bronchodilator) 
airflow obstruction
10 studies examined the effect of the fixed FEV1/
FVC ratio (GOLD criteria) threshold for diagnosis 
of airflow obstruction in COPD [10, 14, 15, 17, 
25–30]. The FEV1/FVC ratio is known to decline 
with age, and a fixed diagnostic threshold of FEV1/
FVC <0.7 after bronchodilator administration does 
not take this into account. These studies compared 
the effect on COPD prevalence when using the fixed 
ratio compared to an age-adjusted definition of 
airflow obstruction or the LLN. The majority of these 
studies used the term “overdiagnosis” to describe a 
situation in which airflow obstruction was present 
using a definition of an FEV1/FVC ratio <0.7, but not 
when using the LLN [10, 15, 17, 25–28]. van Dijk 
et al. [30] and Steinacher et al. [29] used the terms 
“overdiagnosis” and “misdiagnosis” interchangeably 
when describing misclassification due to a diagnosis 
of airflow obstruction based on an FEV1/FVC ratio 
<0.7. Estimates of COPD overdiagnosis due to the 
fixed ratio ranged from 4.6% in a general population 
study that included people aged 40–80 years [27] to 
42.7% in a study of people over the age of 80 years 
referred for spirometry by their general practitioners 
(GPs) [26].
Use of pre-bronchodilator 
spirometry only
One study explored the impact of using pre-
bronchodilator spirometry on COPD prevalence 
[26]. To avoid misclassification with asthma 
(which is characterised by reversible airflow 
obstruction), a diagnosis of COPD must be based 
on airflow obstruction on spirometry performed 
after bronchodilator application. In the study of 
symptomatic adults referred for spirometry by 
their GPs, 25.3% of subjects with an obstructive 
pattern diagnosed by pre-bronchodilator spirometry 
were no longer classified as having COPD on post-
bronchodilator spirometry. These cases were 
considered to be overdiagnosed.
Two studies reported misdiagnoses of physician-
diagnosed COPD that later was found to be asthma 
after performing post-bronchodilator spirometry 
[19, 21].
Alternative diagnosis 
overlapping with COPD
Two studies performed spirometry in patients 
with known heart failure and found that, in this 
population, a substantial proportion of those 
diagnosed with COPD (12.3% in the first study 
[17] and 19.1% in the second study [29]) had 
been misdiagnosed using a definition of airflow 
obstruction based on FEV1/FVC <0.7 rather than 
FEV1/FVC <LLN. There is considerable overlap 
between the clinical features of heart failure and 
COPD.
The authors of one study attempted to detect 
airflow obstruction that was possibly masked by 
heart failure-related restriction (in 13 cases with an 
FEV1/FVC >LLN and an FVC <LLN) by experimentally 
substituting measured FVC by 80% of predicted 
FVC. This led to a decline of FEV1/FVC to <0.7 in 
eight cases and <LLN in seven cases [29].
One study reported that 19.5% of patients 
newly diagnosed with asthma had previously 
received an incorrect diagnosis of COPD and/or 
emphysema [31]. These cases were considered 
to be misdiagnosed cases and were attributed 
to the overlap in clinical features of asthma and 
COPD.
Table 1 Types of overdiagnosis and misdiagnosis
1 Physician COPD diagnosis despite normal spirometry
The physician did not use spirometry to establish a diagnosis of COPD 
(and a normal spirometry was later found in the study)
The physician “ignored” a normal spirometry result
2 Discordant results for COPD diagnosis based on different spirometry-
based definitions for airflow obstruction (e.g. post-bronchodilator  
FEV1/FVC <0.7 or FEV1/FVC <LLN)
3 COPD diagnosis based on pre-bronchodilator spirometry results
4 Comorbidities (e.g. heart failure or asthma) that affect spirometry and 
have clinical features which overlap with COPD
5 Normalisation of abnormal (post-bronchodilator) spirometry at follow-up
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 c
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; m
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, d
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 d
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 b
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 c
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 d
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 p
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 C
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 c
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at
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 p
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Follow-up spirometry 
appears normal
Llordés et al. [10] found that 16% of newly 
diagnosed cases of COPD had normal spirometry 
after 4 weeks of inhalation treatment with 
formoterol and budesonide. These diagnoses were 
named false positives or overdiagnosed cases.
Discussion
Findings of the review
In this review of 28 studies, the terms 
“overdiagnosis” and “misdiagnosis” of COPD 
were used interchangeably to describe the same 
concepts. These concepts included: 1) physician 
COPD diagnosis despite normal spirometry (no 
airflow obstruction at any point) in a situation where 
i) a normal spirometry result was documented 
before the study, ii) spirometry had not been 
performed before the study and the study showed 
normal spirometry results, or iii) it was unclear 
whether a spirometry had been performed before 
the study; 2) discordant results for COPD diagnosis 
based on different spirometry-based definitions 
for airflow obstruction (e.g. post-bronchodilator 
FEV1/FVC <0.7 or FEV1/FVC <LLN); 3) COPD 
diagnosis based on pre-bronchodilator spirometry 
results; 4) comorbidities that have clinical features 
overlapping with COPD and affect spirometry 
interpretation; 5) normalisation of abnormal (post-
bronchodilator) spirometry at follow-up.
Comparison with other definitions 
of overdiagnosis and misdiagnosis
In some COPD studies, “overdiagnosis” has served 
as an umbrella term to include misdiagnosis. 
This is in contrast with the “narrow” definition of 
overdiagnosis, when an asymptomatic person is 
diagnosed with a (true positive) condition, but the 
diagnosis does not yield any change in mortality 
or morbidity for the individual [7]. However, 
this narrow definition poses a challenge when 
applied to COPD, as the diagnosis requires the 
presence of respiratory symptoms and screening 
of asymptomatic individuals is not recommended.
Brodersen et al. [32] proposed a definition of 
overdiagnosis that includes both overdetection 
and overdefinition, both leading to a diagnosis that 
causes more harm than benefit. “Overdetection” 
refers to an abnormal finding (e.g. a pulmonary 
nodule) that was never going to cause any harm, 
abnormalities that do not progress or progress so 
slowly that they will not cause any morbidity or 
mortality (e.g. non-aggressive prostate cancer), 
or that resolve spontaneously [33]. By extension, 
overdetection of COPD describes a diagnosis of 
COPD that, while correct, is not associated with 
any harm to the patient (e.g. mild emphysematous 
changes on computed tomography of the chest 
not requiring treatment and not significantly 
progressing). “Overdefinition” refers to lowering the 
threshold for a risk factor without clear evidence 
that this results in a net benefit (e.g. lowering the 
threshold for what constitutes a normal blood 
pressure) or by expanding disease definitions (e.g. 
pre-diabetes) [32].
The current GOLD definition for COPD (updated 
in 2017) requires the presence of persistent 
respiratory symptoms (in addition to meeting the 
spirometric definition of chronic airflow limitation) 
to make a COPD diagnosis [34]. Applying this 
definition of COPD is likely to reduce the rates of 
overdiagnosis in the population-based studies in 
this review that included asymptomatic patients 
(table 2). Spirometry-based definitions of airflow 
obstruction can result in overdefinition and 
thus overdiagnosis of COPD, e.g. when a FEV1/
FVC ratio threshold of 0.7 is applied in elderly 
people. There is a potential risk of overdetection 
if asymptomatic people are screened for COPD, as 
the connection between mild airflow obstruction 
in asymptomatic people and subsequent 
development of symptomatic COPD is unclear. 
While the importance of early detection of COPD 
is often emphasised, this relates to detecting 
COPD early in symptomatic people. There is 
currently no evidence that supports spirometry 
screening of asymptomatic people for COPD [35]. 
A recent study demonstrated that treatment with 
bronchodilators in mild or moderate COPD can 
ameliorate the decline of lung function, but this 
study was conducted in symptomatic patients [36].
Recommended terminology 
for future research
Future meta-analyses that aim to explore the 
extent of COPD diagnostic errors should ideally 
use consistent terminology. For this purpose, it 
is important that the definitions of overdiagnosis 
and misdiagnosis used in the context of COPD 
are clarified. This review identified one main 
source of what we propose is COPD overdiagnosis: 
spirometry-based overdefinition of COPD based on 
the spirometric definition of airflow obstruction, e.g. 
when a FEV1/FVC ratio threshold of 0.7 is applied 
for airflow obstruction in elderly people. The onus 
lies on guideline contributors and authority bodies 
to provide more accurate definitions of airflow 
obstruction on spirometry.
We identified four sources of misdiagnosis 
of COPD: 1) physician COPD diagnosis despite 
normal spirometry; 2) COPD diagnosis based on 
pre-bronchodilator spirometry results (with normal 
result at follow-up); 3) comorbidities (e.g. heart 
failure, asthma) that affect spirometry and have 
clinical features which overlap with COPD; and 
4) normalisation of abnormal post-bronchodilator 
spirometry at follow-up (e.g. in asthma). 
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Figure 2 demonstrates the variety of factors that need 
to be considered when making a diagnosis of COPD.
Study limitations
A limitation of some of the studies in this 
review is that the prevalence of COPD (and 
COPD overdiagnosis) was only defined based on 
a spirometry definition of airflow obstruction 
(comparable to defining the prevalence of 
arterial hypertension based on blood pressure 
measurements in a population), not taking into 
account that in clinical practice the diagnosis of 
COPD is a complex issue and the clinical history 
(symptoms consistent with COPD, exposure to 
inhaled noxious agent) and ruling out potential 
differential diagnoses are also essential in making 
a diagnosis.
While potential adverse events of overtreatment 
(which can be the result of overdiagnosis) for 
COPD may not be as severe as for overtreatment 
of cancer, it is important to keep in mind that all 
medications have the potential to cause harm and 
are associated with work that patients need to do 
to enact treatment recommendations [37].
While this review has focused on overdiagnosis 
and misdiagnosis, underdiagnosis of COPD is 
even more common and both overdiagnosis and 
underdiagnosis can often be explained by underuse 
or inappropriate use of spirometry [8].
In summary, overdiagnosis of COPD has been 
used in the reviewed literature to describe both a 
false positive diagnosis of COPD and overdefinition 
based on diagnostic criteria. With the introduction 
of the new GOLD definition of COPD requiring 
the presence of symptoms, overdefinition and 
thus overdiagnosis of COPD in population-based 
studies will probably be reduced. Misdiagnosis of 
COPD (in addition to underdiagnosis) remains a 
major diagnostic challenge. To reduce misdiagnosis, 
clinicians should perform (technically correct) 
spirometry in all symptomatic patients with 
clinically suspected COPD.
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